[1. Spencer FA, Kroll A, Lessard D, Emery C, Glushchenko AV, Pacifico L, et al. Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study. J. Thromb. Thrombolysis. 2012;33(3):211-7. DOI: 10.1007/s11239-011-0670-x.10.1007/s11239-011-0670-x22261699]Search in Google Scholar
[2. Ng KW, Loh PK, Sharma VK. Role of investigating thrombophilic disorders in young stroke. Stroke research and treatment. 2011;2011.10.4061/2011/670138303879621331344]Search in Google Scholar
[3. Yokus O, Albayrak M, Balcik OS, Ceran F, Dagdas S, Yilmaz M, et al. Risk factors for thrombophilia in young adults presenting with thrombosis. Int. J. Hematol. 2009;90(5):583-90. DOI: 10.1007/s12185-009-0447-6.10.1007/s12185-009-0447-619937485]Search in Google Scholar
[4. Jadaon MM. Epidemiology of activated protein C resistance and Factor V Leiden mutation in the Mediterranean Region. Mediterr. J. Hematol. Infect. Dis. 2011;3:e2011037. DOI: 10.4084/mjhid.2011.037 DOI: 10.4084/mjhid.2011.054.10.4084/mjhid.2011.037]Search in Google Scholar
[5. Jadaon MM. Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region. Mediterr.]Search in Google Scholar
[J. Hematol. Infect. Dis. 2011;3(1):e2011054. DOI: 10.4084/mjhid.2011.037 DOI: 10.4084/mjhid.2011.054.10.4084/mjhid.2011.037]Search in Google Scholar
[6. Prandoni P. Links between arterial and venous disease. J. Intern. Med. 2007;262(3):341-50. DOI: 10.1111/j.1365-2796.2007.01815.x.10.1111/j.1365-2796.2007.01815.x17697155]Search in Google Scholar
[7. Prandoni P. Venous and arterial thrombosis: Two aspects of the same disease? Clin. Epidemiol. 2009;1:1. DOI: 10.1016/j.ejim.2009.02.001 DOI: 10.2147/clep. s4780.10.1016/j.ejim.2009.02.00119782933]Search in Google Scholar
[8. Collaboration HS. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288(16):2015-22. DOI: 10.1001/ jama.288.16.2015.10.1001/jama.288.16.201512387654]Search in Google Scholar
[9. Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: an overview. Arch. Pathol. Lab. Med. 2007;131(6):872-84.]Search in Google Scholar
[10. Trenor CC, Chung RJ, Michelson AD, Neufeld EJ, Gordon CM, Laufer MR, et al. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011;127(2):347-57. DOI: 10.1542/ peds.2010-2221.10.1542/peds.2010-2221302541721199853]Search in Google Scholar
[11. Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, et al. Clinical guidelines for testing for heritable thrombophilia. Br. J. Haematol. 2010;149(2):209-20. DOI: 10.1111/j.1365-2141.2009.08022.x.10.1111/j.1365-2141.2009.08022.x20128794]Search in Google Scholar
[12. Wu O, Robertson L, Twaddle S, Lowe G, Clark P, Greaves M, et al. Screening for thrombophilia in highrisk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. 2006.10.3310/hta1011016595080]Search in Google Scholar
[13. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64-7. DOI: 10.1038/369064a0.10.1038/369064a08164741]Search in Google Scholar
[14. Ferraresi P, Marchetti G, Legnani C, Cavallari E, Castoldi E, Mascoli F, et al. The heterozygous 20210G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler. Thromb. Vasc. Biol. 1997;17(11):2418-22. DOI: 10.1161/01.ATV.17.11.2418.10.1161/01.ATV.17.11.2418]Search in Google Scholar
[15. A ZC, Yang Y, Zhang SZ, Li N, Zhang W. Single nucleotide polymorphism C677T in the methylenetetrahydrofolate reductase gene might be a genetic risk factor for infertility for Chinese men with azoospermia or severe oligozoospermia. Asian J Androl. 2007;9(1):57-62. DOI: 10.1111/j.1745-7262.2007.00225.x.10.1111/j.1745-7262.2007.00225.x16888682]Search in Google Scholar
[16. Wu J, Li Y-z, Ma H-y, Bai J, Chen F, Fu S-b. Association between single nucleotide polymorphisms of MTHFR gene and susceptibility of psoriasis. Int J Genet. 2007;30(3):173-7.]Search in Google Scholar
[17. Shaheen K, Alraies MC, Alraiyes AH, Christie R. Factor V Leiden: How great is the risk of venous thromboembolism? Cleve. Clin. J. Med. 2012;79(4):265-72. DOI: 10.3949/ccjm.79a.11072.10.3949/ccjm.79a.1107222473726]Search in Google Scholar
[18. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular Disease in Women A Statement for Healthcare Professionals From the American Heart Association.Circulation. 1997;96(7):2468-82. DOI: 10.1161/01. CIR.96.7.2468]Search in Google Scholar
[10. Trenor CC, Chung RJ, Michelson AD, Neufeld EJ, Gordon CM, Laufer MR, et al. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011;127(2):347-57. DOI: 10.1542/ peds.2010-2221.10.1542/peds.2010-2221302541721199853]Search in Google Scholar
[11. Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, et al. Clinical guidelines for testing for heritable thrombophilia. Br. J. Haematol. 2010;149(2):209-20. DOI: 10.1111/j.1365-2141.2009.08022.x.10.1111/j.1365-2141.2009.08022.x20128794]Search in Google Scholar
[12. Wu O, Robertson L, Twaddle S, Lowe G, Clark P, Greaves M, et al. Screening for thrombophilia in highrisk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. 2006.10.3310/hta10110]Search in Google Scholar
[13. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64-7. DOI: 10.1038/369064a0.10.1038/369064a0]Search in Google Scholar
[14. Ferraresi P, Marchetti G, Legnani C, Cavallari E, Castoldi E, Mascoli F, et al. The heterozygous 20210G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler.Thromb. Vasc. Biol. 1997;17(11):2418-22. DOI: 10.1161/01.ATV.17.11.2418.10.1161/01.ATV.17.11.2418]Search in Google Scholar
[15. A ZC, Yang Y, Zhang SZ, Li N, Zhang W. Single nucleotide polymorphism C677T in the methylenetetrahydrofolate reductase gene might be a genetic risk factor for infertility for Chinese men with azoospermia or severe oligozoospermia. Asian J Androl. 2007;9(1):57-62. DOI: 10.1111/j.1745-7262.2007.00225.x.10.1111/j.1745-7262.2007.00225.x16888682]Search in Google Scholar
[16. Wu J, Li Y-z, Ma H-y, Bai J, Chen F, Fu S-b. Association between single nucleotide polymorphisms of MTHFR gene and susceptibility of psoriasis. Int J Genet. 2007;30(3):173-7.]Search in Google Scholar
[17. Shaheen K, Alraies MC, Alraiyes AH, Christie R. Factor V Leiden: How great is the risk of venous thromboembolism? Cleve. Clin. J. Med. 2012;79(4):265-72.DOI: 10.3949/ccjm.79a.11072.10.3949/ccjm.79a.1107222473726]Search in Google Scholar
[18. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular Disease in Women A Statement for Healthcare Professionals From the American Heart Association. Circulation. 1997;96(7):2468-82. DOI: 10.1161/01. CIR.96.7.2468. ]Search in Google Scholar
[19. Lowe G. Common risk factors for both arterial and venous thrombosis. Br. J. Haematol. 2008;140(5):488-95. DOI: 10.1111/j.1365-2141.2007.06973.x.10.1111/j.1365-2141.2007.06973.x18275426]Search in Google Scholar
[20. Zoller B, de Frutos PG, Hillarp A, Dahlback B. Thrombophilia as a multigenic disease. Haematologica. 1999;84(1):59-70.]Search in Google Scholar
[21. Chan MY, Andreotti F, Becker RC. Hypercoagulable states in cardiovascular disease. Circulation. 2008;118(22):2286-97. DOI: 10.1161/CIRCULATIONAHA.108.778837.10.1161/CIRCULATIONAHA.108.77883719029477]Search in Google Scholar
[22. Otten AM, Maas AH, Ottervanger JP, Kloosterman A, van’t Hof AW, Dambrink JHE, et al. Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age. European Heart Journal: Acute Cardiovascular Care. 2013;2(4):334-41. DOI: 10.1177/2048872612475270.10.1177/2048872612475270382182524338292]Search in Google Scholar
[23. Yang X-P, Reckelhoff JF. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr. Opin. Nephrol. Hypertens. 2011;20(2):133. DOI: 10.1097/ MNH.0b013e3283431921.10.1097/MNH.0b013e3283431921312388421178615]Search in Google Scholar
[24. Maas A, Appelman Y. Gender differences in coronary heart disease. Neth. Heart J. 2010;18(12):598-603. DOI: 10.1007/s12471-010-0841-y.10.1007/s12471-010-0841-y301860521301622]Search in Google Scholar
[25. Hanson NQ, Aras O, Yang F, Tsai MY. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin. Chem. 2001;47(4):661-6.]Search in Google Scholar
[26. de Bree A, Verschuren WM, Bjorke-Monsen AL, van der Put NM, Heil SG, Trijbels FJ, et al. Effect of the methylenetetrahydrofolate reductase 677C-- >T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am. J. Clin. Nutr. 2003;77(3):687-93.]Search in Google Scholar
[27. Rosendorff A, Dorfman DM. Activated protein C resistance and factor V Leiden. Arch. Pathol. Lab. Med. 2007;131(6):866-71.]Search in Google Scholar
[28. Djordjevic V, Rakicevic L, Mikovic D, Kovac M, Miljic P, Radojkovic D, et al. Prevalence of factor V leiden, factor V cambridge, factor II G20210A and methylenetetrahydrofolate reductase C677T mutations in healthy and thrombophilic Serbian populations. Acta Haematol. 2004;112(4):227-9. DOI: 10.1159/000081280. 10.1159/00008128015564739]Search in Google Scholar
[29. Jukić I, Bingulac-Popović J, Đogić V, Babić I, Culej J, Tomičić M, et al. ABO blood groups and genetic risk factors for thrombosis in Croatian population. Croat. Med. J. 2009;50(6):550-8. DOI: 10.3325/ cmj.2009.50.550.10.3325/cmj.2009.50.550280208820017223]Search in Google Scholar
[30. Stankovics J, Melegh B, Nagy A, Kis A, Molnar J, Losonczy H, et al. [Incidence of factor V G1681A (Leiden) mutation in samplings from the Hungarian population]. Orv. Hetil. 1998;139(19):1161-3.]Search in Google Scholar
[31. Cushman M, Rosendaal FR, Psaty BM, Cook EF, Valliere J, Kuller LH, et al. Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study. Thromb. Haemost. 1998;79(5):912-5.]Search in Google Scholar
[32. Rosendaal F, Siscovick D, Schwartz S, Beverly R, Psaty B, Longstreth Jr W, et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood. 1997;89(8):2817-21.10.1182/blood.V89.8.2817]Search in Google Scholar
[33. Hotoleanu C, Popp R, Trifa A. Factor V Leiden, prothrombin G20210A and MTHFR C677T mutations in Romanian patients with deep venous thrombosis. HVM Bioflux. 2014;6(1):15-9.]Search in Google Scholar
[34. Alfirevic Z, Simundic A-M, Nikolac N, Sobocan N, Alfirevic I, Stefanovic M, et al. Frequency of factor II G20210A, factor V Leiden, MTHFR C677T and PAI-1 5G/4G polymorphism in patients with venous thromboembolism: Croatian case-control study. Biochemia Medica. 2010;20(2):229-35. DOI: 10.11613/ BM.2010.028.10.11613/BM.2010.028]Search in Google Scholar
[35. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation. 1999;99(8):999-1004. DOI: 10.1161/01.CIR.99.8.99910.1161/01.CIR.99.8.999]Search in Google Scholar
[36. Hotoleanu C, Trifa A, Popp R, Fodor D. The Importance of homozygous polymorphisms of methylenetetrahydrofolate reductase gene in romanian patients with idiopathic venous thromboembolism. Balkan medical journal. 2013;30(2):197. DOI: 10.5152/balkanmedj. 2013.7159.10.5152/balkanmedj]Search in Google Scholar
[37. Shmeleva VM, Kapustin SI, Papayan LP, Sobczyńska- Malefora A, Harrington DJ, Savidge GF. Prevalence of hyperhomocysteinemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia. Thromb. Res. 2003;111(6):351-6. DOI: 10.1016/j.thromres. 2003.10.004. ]Search in Google Scholar
[38. Nizankowska-Mogilnicka E, Adamek L, Grzanka P, Domagala T, Sanak M, Krzanowski M, et al. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis. Eur. Respir. J. 2003;21(1):25-30. DOI: 10.1183/09031936.03.00034302.10.1183/09031936.03.0003430212570104]Search in Google Scholar
[39. Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR. No association between the common MTHFR 677C→ T polymorphism and venous thrombosis: results from the MEGA study. Arch. Intern. Med. 2007;167(5):497-501.DOI: 10.1001/archinte.167.5.497.10.1001/archinte.167.5.49717353498]Search in Google Scholar
[40. De Stefano V, Zappacosta B, Persichilli S, Rossi E, Casorelli I, Paciaroni K, et al. Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease. Br. J. Haematol. 1999;106(2):564-8. DOI: 10.1046/j.1365-2141.1999.01613.x. 10.1046/j.1365-2141.1999.01613.x10460623]Search in Google Scholar